Literature DB >> 29796994

Incidence and survival of primary central nervous system lymphoma (PCNSL): results from the Girona cancer registry (1994-2013).

R Fuentes-Raspall1, M Solans2,3,4, C Auñon-Sanz1, M Saez5,6, R Marcos-Gragera6,7,8.   

Abstract

Entities:  

Keywords:  Incidence; Population-based; Primary central nervous system lymphoma (PCNSL); Spain; Survival

Mesh：

Year:  2018        PMID： 29796994     DOI： 10.1007/s12094-018-1890-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  8 in total

1.  Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing.

Authors:  Gunilla Enblad; Gustaf Martinsson; Eva Baecklund; Göran Hesselager; Christer Sundström; Rosie-Marie Amini; Hans Hagberg
Journal:  Acta Oncol       Date:  2017-01-13       Impact factor: 4.089

2.  Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994-2013).

Authors:  Rafael Fuentes-Raspall; Marta Solans; Aina Roca-Barceló; Loreto Vilardell; Montse Puigdemont; Sonia Del Barco; Raquel Comas; Adelaida García-Velasco; Aurora Astudillo; Mª Carme Carmona-Garcia; Rafael Marcos-Gragera
Journal:  Cancer Epidemiol       Date:  2017-07-21       Impact factor: 2.984

3.  Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007.

Authors:  I Baldi; A Gruber; A Alioum; E Berteaud; P Lebailly; A Huchet; T Tourdias; G Kantor; J P Maire; A Vital; H Loiseau
Journal:  Neuro Oncol       Date:  2011-10-06       Impact factor: 12.300

4.  Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.

Authors:  Gitty A C van der Sanden; Leo J Schouten; Jos A A M van Dijck; Joke P van Andel; Richard W M van der Maazen; Jan-Willem W Coebergh
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

5.  Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.

Authors:  M Krogh-Jensen; F D'Amore; M K Jensen; B E Christensen; K Thorling; M Pedersen; P Johansen; A M Boesen; E Andersen
Journal:  Leuk Lymphoma       Date:  1995-10

6.  Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013.

Authors:  Sandra Eloranta; Elsa Brånvall; Fredrik Celsing; Karin Papworth; Maria Ljungqvist; Gunilla Enblad; Karin Ekström-Smedby
Journal:  Eur J Haematol       Date:  2017-10-25       Impact factor: 2.997

7.  Trends in primary central nervous system lymphoma incidence and survival in the U.S.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; Caroline Besson; Christina A Clarke; Lindsay M Morton; Leticia Nogueira; Karen Pawlish; Elizabeth L Yanik; Gita Suneja; Eric A Engels
Journal:  Br J Haematol       Date:  2016-03-28       Impact factor: 8.615

8.  Trends in primary cerebral lymphoma.

Authors:  J M Lutz; M P Coleman
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640
  8 in total
  3 in total

1.  Changing Incidence and Survival of Primary Central Nervous System Lymphoma in Australia: A 33-Year National Population-Based Study.

Authors:  Alexandra L Farrall; Justine R Smith
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

2.  Primary peripheral T-cell central nervous system lymphoma.

Authors:  Cylaina E Bird; Jeffrey I Traylor; Jenna Thomas; James P Caruso; Benjamin Kafka; Flavia Rosado; Kyle M Blackburn; Kimmo J Hatanpaa; Kalil G Abdullah
Journal:  Surg Neurol Int       Date:  2021-09-13

3.  The International Vitreoretinal B-Cell Lymphoma Registry: a protocol paper.

Authors:  Justine R Smith; Alexandra L Farrall; Janet L Davis; Joke H de Boer; Anthony J Hall; Manabu Mochizuki; H Nida Sen; Hiroshi Takase; Ninette H Ten Dam-van Loon; Valérie Touitou; Daniel V Vasconcelos-Santos; David J Wilson; Steven Yeh; Mark H B Radford
Journal:  BMJ Open       Date:  2022-07-28       Impact factor: 3.006
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.